指南推荐药物与多重慢病老年人身体功能的关系
该前瞻性观察性队列研究纳入3273名65岁及以上社区居住的Medicare Current Beneficiary Survey参与者,分析房颤、冠心病、抑郁、糖尿病或心衰患者中指南推荐药物与自报身体功能下降的关联。总体样本中六种指南推荐药物均与功能下降无关,但在低多重用药暴露组中,心衰患者使用肾素-血管紧张素系统阻滞剂与功能下降风险降低相关(HR=0.40,95%CI=0.16-0.99),糖尿病患者使用他汀与功能下降风险升高相关(HR=2.27,95%CI=1.39-3.69)。
要点
- 总体样本中指南推荐药物与身体功能下降无显著关联。
- 低多重用药组心衰患者用RAS阻滞剂与功能下降风险降低相关。
- 低多重用药组糖尿病患者用他汀与功能下降风险升高相关。
核心结论
- 在多重慢病老年人中,房颤、冠心病、抑郁、糖尿病和心衰的指南推荐药物总体上与自报身体功能下降无关,但低多重用药者中部分药物存在关联。
研究设计与样本
- 前瞻性观察性队列研究,纳入Medicare Current Beneficiary Survey中3273名65岁及以上社区居住的老年人。
主要发现
- 总体样本功能下降风险最高为心衰患者35.4%(95%CI=26.3-44.5),最低为房颤患者20.6%(95%CI=14.9-26.2)。
- 总体样本中六种指南推荐药物均与身体功能下降无显著关联。
- 低多重用药组心衰患者使用肾素-血管紧张素系统阻滞剂与功能下降风险降低相关(HR=0.40,95%CI=0.16-0.99)。
- 低多重用药组糖尿病患者使用他汀与功能下降风险升高相关(HR=2.27,95%CI=1.39-3.69)。
关键数值与推荐
- 多重用药定义为同时使用<7种 vs ≥7种药物。
- 纳入条件为患有房颤、冠心病、抑郁、糖尿病或心衰。
临床怎么用
- 对多重慢病老年人处方指南推荐药物时,应结合多重用药状态评估身体功能下降风险。
- 低多重用药的心衰患者使用RAS阻滞剂可能需关注功能保护作用。
- 低多重用药的糖尿病患者使用他汀时需监测身体功能变化。
局限性
- 身体功能下降为自报结局,可能存在报告偏倚。
- 研究为观察性设计,无法确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: The benefit or harm of a single medication recommended for one specific condition can be difficult to determine in individuals with multiple chronic conditions and polypharmacy. There is limited information on the associations between guideline-recommended medications and physical function in older adults with multiple chronic conditions. The objective of this study was to estimate the beneficial or harmful associations between guideline-recommended medications and decline in physical function in older adults with multiple chronic conditions. DESIGN: Prospective observational cohort. SETTING: National. PARTICIPANTS: Community-dwelling adults aged 65 and older from the Medicare Current Beneficiary Survey study (N = 3,273). Participants with atrial fibrillation, coronary artery disease, depression, diabetes mellitus, or heart failure were included. MEASUREMENTS: Self-reported decline in physical function; guideline-recommended medications; polypharmacy (taking <7 vs ≥7 concomitant medications); chronic conditions; and sociodemographic, behavioral, and health risk factors. RESULTS: The risk of decline in function in the overall sample was highest in participants with heart failure (35.4%, 95% confidence interval (CI) = 26.3-44.5) and lowest for those with atrial fibrillation (20.6%, 95% CI = 14.9-26.2). In the overall sample, none of the six guideline-recommended medications was associated with decline in physical function across the five study conditions, although in the group with low polypharmacy exposure, there was lower risk of decline in those with heart failure taking renin angiotensin system blockers (hazard ratio (HR) = 0.40, 95% CI = 0.16-0.99) and greater risk of decline in physical function for participants with diabetes mellitus taking statins (HR = 2.27, 95% CI = 1.39-3.69). CONCLUSIONS: In older adults with multiple chronic conditions, guideline-recommended medications for atrial fibrillation, coronary artery disease, depression, diabetes mellitus, and heart failure were largely not associated with self-reported decline in physical function, although there were associations for some medications in those with less polypharmacy.
引用
- McAvay G, Allore HG, Cohen AB, et al. Guideline-Recommended Medications and Physical Function in Older Adults with Multiple Chronic Conditions. J Am Geriatr Soc. 2017. PMID: 28905359. doi:10.1111/jgs.15065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。